Auspex Pharmaceuticals, Inc.
🏢 View company profile →73Patents
69Active
73Granted
53Portfolio score
Filing activity: Jan 16, 2004 → Aug 2, 2022 · 22 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8524733B2 | Benzoquinoline inhibitors of vesicular monoamine transporter 2 | Chemistry; Metallurgy | 43 | Active |
| US7638651B2 | Substituted cyclohexanones | Chemistry; Metallurgy | 28 | Active |
| US7745665B2 | Substituted phenethylamines | Chemistry; Metallurgy | 22 | Active |
| US10166183B2 | Pharmaceutical formulations | Human Necessities | 20 | Active |
| US7598273B2 | Inhibitors of the gastric H+, K+-ATPase with enhanced therapeutic properties | Human Necessities | 18 | Active |
| US7456317B2 | Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity | Chemistry; Metallurgy | 17 | Active |
| US9233959B2 | Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 | Chemistry; Metallurgy | 16 | Active |
| US8575348B2 | Quinolone inhibitors of lipoprotein-associated phospholipase A2 | Human Necessities | 11 | Active |
| US9296739B2 | Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 | Chemistry; Metallurgy | 11 | Active |
| US8299084B2 | Piperidine inhibitors of Janus kinase 3 | Emerging Cross-Sectional Technologies | 10 | Active |
| US7872013B2 | Preparation and utility of opioid analgesics | Chemistry; Metallurgy | 9 | Active |
| US9346800B2 | Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 | Chemistry; Metallurgy | 9 | Active |
| US8383823B2 | Substituted N-aryl pyridinones | Chemistry; Metallurgy | 8 | Active |
| US9458082B2 | Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity | Chemistry; Metallurgy | 7 | Active |
| US10722479B2 | Dimethoxyphenyl inhibitors of vesicular monoamine transporter 2 | Chemistry; Metallurgy | 7 | Active |
| US9814708B2 | Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 | Chemistry; Metallurgy | 6 | Active |
| US7691904B2 | pH sensitive prodrugs of 2,6-diisopropylphenol | Human Necessities | 5 | Active |
| US10959996B2 | Methods for the treatment of abnormal involuntary movement disorders | Human Necessities | 5 | Active |
| US9255104B2 | Cyclopropyl modulators of P2Y12 receptor | Chemistry; Metallurgy | 5 | Active |
| US7767860B2 | Substituted amino alcohols | Chemistry; Metallurgy | 5 | Active |
| US9498481B2 | Cyclopropyl modulators of P2Y12 receptor | Chemistry; Metallurgy | 5 | Active |
| US10626105B2 | Deuterium-substituted pyridin- and pyrimidin-2-yl-methylamine compounds | Chemistry; Metallurgy | 5 | Active |
| US9585884B2 | Pyrimidinone inhibitors of lipoprotein-associated phospholipase A2 | Chemistry; Metallurgy | 5 | Active |
| US8802850B2 | Cyclopropyl modulators of P2Y12 receptor | Chemistry; Metallurgy | 4 | Active |
| US7250412B2 | PH sensitive prodrugs of 2,6-Diisopropylphenol | Human Necessities | 3 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.